{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:50:38Z","timestamp":1777560638481,"version":"3.51.4"},"reference-count":31,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNS"],"published-print":{"date-parts":[[2006,11]]},"abstract":"<jats:sec>\n<jats:title>Object<\/jats:title>\n<jats:p>Impairment of endothelial nitric oxide synthase (eNOS), endothelium-dependent relaxation, and cerebrovascular autoregulation all occur in vasospastic cerebral arteries following subarachnoid hemorrhage (SAH). The 3-hy-droxy-3-methylglutaryl coenzyme A reductase inhibitors, or statins, both improve endothelial function and increase eNOS messenger RNA, protein, and enzymatic activity threefold. Increasing experimental evidence in animal models of SAH suggests that statins may ameliorate cerebral vasospasm. The authors hypothesized that patients chronically treated with statins would have a decreased risk of symptomatic vasospasm after SAH.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The authors retrospectively reviewed the charts of 115 patients with SAH who were consecutively admitted to the Neuroscience Intensive Care Unit of Duke University between 1998 and 2001. The independent association of statin therapy to symptomatic vasospasm was assessed using multivariate logistic regression analysis. Fifteen patients (13%) admitted with SAH were receiving statin therapy for at least 1 month before admission. Forty-nine patients (43%) experienced symptomatic vasospasm a mean of 5.8 \u00b1 3 days after onset of SAH. Current statin therapy on admission (odds ratio [OR] 0.09, 95% confidence interval [CI] 0.01\u20130.77) was independently associated with an 11-fold reduction in the risk of symptomatic vasospasm. Fisher Grade 3 SAH (OR 2.82, 95% CI 1.50\u20135.71) and rupture of anterior cerebral or internal carotid artery aneurysm (OR 3.77, 95% CI 1.29\u201310.91) were independently associated with an increased risk of symptomatic vasospasm.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>In this retrospective case series, patients who received statin therapy for at least 1 month demonstrated an 11-fold decrease in the risk of developing symptomatic vasospasm after SAH.<\/jats:p><\/jats:sec>","DOI":"10.3171\/jns.2006.105.5.671","type":"journal-article","created":{"date-parts":[[2008,1,24]],"date-time":"2008-01-24T12:43:01Z","timestamp":1201178581000},"page":"671-674","source":"Crossref","is-referenced-by-count":65,"title":["Risk of cerebral vasopasm after subarachnoid hemorrhage reduced by statin therapy: a multivariate analysis of an institutional experience"],"prefix":"10.3171","volume":"105","author":[{"given":"Matthew J.","family":"McGirt","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, The Johns Hopkins Hospital, Baltimore, Maryland; and Departments of Neurosurgery and Neurology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Blessing","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Johns Hopkins Hospital, Baltimore, Maryland; and Departments of Neurosurgery and Neurology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Alexander","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Johns Hopkins Hospital, Baltimore, Maryland; and Departments of Neurosurgery and Neurology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahid M.","family":"Nimjee","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Johns Hopkins Hospital, Baltimore, Maryland; and Departments of Neurosurgery and Neurology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme F.","family":"Woodworth","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Johns Hopkins Hospital, Baltimore, Maryland; and Departments of Neurosurgery and Neurology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan H.","family":"Friedman","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Johns Hopkins Hospital, Baltimore, Maryland; and Departments of Neurosurgery and Neurology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmelo","family":"Graffagnino","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Johns Hopkins Hospital, Baltimore, Maryland; and Departments of Neurosurgery and Neurology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel T.","family":"Laskowitz","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Johns Hopkins Hospital, Baltimore, Maryland; and Departments of Neurosurgery and Neurology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Lynch","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Johns Hopkins Hospital, Baltimore, Maryland; and Departments of Neurosurgery and Neurology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1-1050671","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1161\/01.STR.32.4.980","article-title":"Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice","volume":"32","year":"2001"},{"key":"b2-1050671","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1161\/01.STR.30.7.1402","article-title":"Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage","volume":"30","year":"1999"},{"key":"b3-1050671","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/00006123-200003000-00001","article-title":"Molecular keys to the problems of cerebral vasospasm","volume":"46","year":"2000"},{"key":"b4-1050671","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3171\/jns.1992.76.5.0830","article-title":"The effect of chronic subarachnoid hemorrhage on basal endothelium-derived relaxing factor activity in intrathecal cerebral arteries","volume":"76","year":"1992"},{"key":"b5-1050671","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"8880","DOI":"10.1073\/pnas.95.15.8880","article-title":"Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase","volume":"95","year":"1998"},{"key":"b6-1050671","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1227\/00006123-198001000-00001","article-title":"Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning","volume":"6","year":"1980"},{"key":"b7-1050671","series-title":"Nature","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","year":"1990"},{"key":"b8-1050671","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3171\/jns.1993.78.4.0548","article-title":"A randomized trial of nicardipine in subarachnoid hemorrhage: angiographic and transcranial Doppler ultrasound results. A report of the Cooperative Aneurysm Study","volume":"78","year":"1993"},{"key":"b9-1050671","series-title":"Neurosurgery","first-page":"562","article-title":"Changes in endothelial nitric oxide synthase mRNA during vasospasm after subarachnoid hemorrhage in monkeys","volume":"39","year":"1996"},{"key":"b10-1050671","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3171\/jns.1988.69.2.0247","article-title":"Subarachnoid hemorrhage inhibition of endothelium-derived relaxing factor in rabbit basilar artery","volume":"69","year":"1988"},{"key":"b11-1050671","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3171\/jns.1968.28.1.0014","article-title":"Surgical risk as related to time of intervention in the repair of intracranial aneurysms","volume":"28","year":"1968"},{"key":"b12-1050671","series-title":"Am J Physiol","first-page":"H1074","article-title":"Mechanisms of endothelium-dependent vascular smooth muscle relaxation elicited by bradykinin and VIP","volume":"253","year":"1987"},{"key":"b13-1050671","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1161\/01.STR.16.4.562","article-title":"Cerebral vasospasm following aneurysmal subarachnoid hemorrhage","volume":"16","year":"1985"},{"key":"b14-1050671","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1161\/01.STR.24.3.392","article-title":"Subarachnoid hemorrhage and endothelial Larginine pathway in small brain stem arteries in dogs","volume":"24","year":"1993"},{"key":"b15-1050671","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"31725","DOI":"10.1074\/jbc.272.50.31725","article-title":"Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase","volume":"272","year":"1997"},{"key":"b16-1050671","series-title":"Circulation","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","article-title":"Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors","volume":"97","year":"1998"},{"key":"b17-1050671","series-title":"J Clin Invest","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1172\/JCI118332","article-title":"Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen","volume":"96","year":"1995"},{"key":"b18-1050671","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1161\/01.STR.0000177879.11607.10","article-title":"Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage. Results of a pilot randomized clinical trial","volume":"36","year":"2005"},{"key":"b19-1050671","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1161\/01.STR.0000038986.68044.39","article-title":"Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage","volume":"33","year":"2002"},{"key":"b20-1050671","series-title":"Clin Neurosurg","first-page":"320","article-title":"Statins for the treatment of neurological injury: a role beyond cholesterol lowering","volume":"51","year":"2004"},{"key":"b21-1050671","series-title":"Circulation","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1161\/01.CIR.95.5.1126","article-title":"Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month","volume":"95","year":"1997"},{"key":"b22-1050671","series-title":"Anesth Analg","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1097\/00000539-200104000-00035","article-title":"Micro-vascular endothelial dysfunction and its mechanism in a rat model of subarachnoid hemorrhage","volume":"92","year":"2001"},{"key":"b23-1050671","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1227\/01.NEU.0000153925.96889.8A","article-title":"Effect of prior statin use on functional outcome and delayed vasopasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study","volume":"56","year":"2005"},{"key":"b24-1050671","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3171\/jns.1996.84.4.0648","article-title":"Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm","volume":"84","year":"1996"},{"key":"b25-1050671","series-title":"Crit Care Med","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1097\/00003246-200004000-00012","article-title":"Early identification of patients at risk for symptomatic vasospasm after aneurysmal subarachnoid hemorrhage","volume":"28","year":"2000"},{"key":"b26-1050671","series-title":"Acta Neurochir (Wien)","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/BF01808542","article-title":"A statistical analysis of factors related to symptomatic cerebral vasospasm","volume":"127","year":"1994"},{"key":"b27-1050671","series-title":"J Cereb Blood Flow Metab","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/00004647-200109000-00004","article-title":"Relation of cerebral energy metabolism and extra-cellular nitrite and nitrate concentrations in patients after aneurysmal subarachnoid hemorrhage","volume":"21","year":"2001"},{"key":"b28-1050671","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1212\/01.WNL.0000154523.21633.0E","article-title":"SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage","volume":"64","year":"2005"},{"key":"b29-1050671","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1161\/01.STR.0000176743.67564.5d","article-title":"Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage. A phase II randomized placebo-controlled trial","volume":"36","year":"2005"},{"key":"b30-1050671","series-title":"Neurosurgery","first-page":"1237","article-title":"Role of transcranial Doppler monitoring in the diagnosis of cerebral vasospasm after subarachnoid hemorrhage","volume":"44","year":"1999"},{"key":"b31-1050671","series-title":"J Am Coll Cardiol","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S0735-1097(97)00537-8","article-title":"Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys","volume":"31","year":"1998"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/105\/5\/article-p671.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/105\/5\/article-p671.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/105\/5\/article-p671.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T09:46:43Z","timestamp":1709977603000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/105\/5\/article-p671.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":31,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.3171\/jns.2006.105.5.671","relation":{},"ISSN":["0022-3085"],"issn-type":[{"value":"0022-3085","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}